ARK Genomic Revolution ETF stock is traded at $43.62, with a volume of 1,541,675. It is down -5.75% in the last 24 hours and down -11.84% over the past month. The investment seeks long-term growth of capital.
The fund is an actively-managed exchange-traded fund ("ETF") that will invest under normal circumstances primarily (at least 80% of its assets) in domestic and foreign equity securities of companies across multiple sectors, including healthcare, information technology, materials, energy and consumer discretionary, that are relevant to the fund's investment theme of the genomics revolution ("Genomics Revolution Companies"). It is non-diversified.
Previous Close:
$46.28
Open:
$44.43
24h Volume:
1,541,675
Relative Volume:
0.29
Market Cap:
$1.90B
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-2.24%
1M Performance:
-11.84%
6M Performance:
+46.77%
1Y Performance:
+54.13%
1-Day Range:
$42.72$44.43
1-Week Range:
$42.72$48.76
52-Week Range:
$24.60$58.83
ARK Genomic Revolution ETF Stock (ARKG) Company Profile
Name
ARK Genomic Revolution ETFSector
FinancialIndustry
Exchange Traded FundPhone
855-406-1506Address
USAMarket Cap
Revenue
Net Income
Cash Flow
EPS